ABSTRACT
Herpes simplex virus 1 (HSV-1) utilizes cellular RNA polymerase II (Pol) to transcribe its genes in one of two phases. In the latent phase, viral transcription is highly restricted, but during the productive lytic phase, more than 80 genes are expressed in a temporally coordinated cascade. In this study, we used Precision nuclear Run On followed by deep Sequencing (PRO-Seq) to characterize early viral transcriptional events using HSV-1 immediate early (IE) gene mutants, corresponding genetically repaired viruses, and wild-type virus. Unexpectedly, in the absence of the IE genes ICP4, ICP22, and ICP0 at 1.5 hours postinfection (hpi), we observed high levels of aberrant transcriptional activity across the mutant viral genomes but substantially less on either wild-type or the congenic repaired virus genomes. This feature was particularly prominent in the absence of ICP4 expression. Cycloheximide treatment during infection with both the ICP4 and ICP22 mutants and their respective genetic repairs did not alter the relative distribution of Pol activity, but it increased overall activity across both viral genomes, indicating that both virion components and at least some de novo protein synthesis were required for full repression. Overall, these data reveal that prior to their role in transcriptional activation, IE gene products and virion components first repress transcription and that the HSV-1 lytic transcriptional cascade is mediated through subsequent derepression steps.
IMPORTANCE HSV-1 transcription during productive replication is believed to comprise a series of activation steps leading to a specific sequence of gene expression. Here, we show that virion components and IE gene products ICP0, ICP4, and ICP22 first repress viral gene transcription to various degrees before subsequently activating specific gene subsets. It follows that the entire HSV transcriptional program involves a series of steps to sequentially reverse this repression. This previously uncharacterized repressive activity of IE genes very early in infection may represent an important checkpoint allowing HSV-1 to orchestrate either the robust lytic transcriptional cascade or the more restricted transcriptional program during latency.
KEYWORDS: human herpesviruses, transcription, transcriptional regulation, transcriptional repression
INTRODUCTION
Herpes simplex virus 1 (HSV-1) expresses its double-stranded DNA genome by using cellular RNA polymerase II (Pol) in two phases. During the latent phase in which the genome is maintained as an episome in sensory neurons, viral transcription is mostly limited to the production of the latency transcript (LAT). In the productive phase, which usually occurs in epithelial cells, transcription of its more than 80 genes occurs in a cascade involving sequential activation of different gene subsets, starting from pre-immediate early, followed sequentially by immediate early (IE, or α), early (E, or β), leaky late (LL, or γ1), and true late (L, γ2) genes (1, 2). To initiate productive replication, HSV commandeers Pol for viral transcription by introducing VP16 from the virion into the newly infected cell. VP16 binds a specific motif in viral IE promoters and recruits cellular transcription factors, HCF and Oct-1, to these sites to drive Pol initiation (3, 4). Similar to cellular genes, viral gene expression is regulated through promoter-proximal pausing (PPP) of Pol, followed by release into the gene body (5).
The IE genes are expressed by 1 h postinfection (hpi) and include α0, α4, and α22/US1, encoding ICP0, ICP4, and ICP22, respectively (6). ICP0 and ICP4 are also virion components that are introduced into the cell upon the initiation of infection (7). ICP4 is an essential activator and repressor of both viral (8, 9) and host genes (10), while ICP0 is an E3 ubiquitin ligase that leads to degradation of a set of cellular proteins that would otherwise silence the viral genome early in infection (11). ICP22 negatively regulates Pol processivity and release to elongation through reduction of serine 2 phosphorylation on the Pol C-terminal domain (CTD) (12). This negative elongation activity of ICP22 is important for enhancing promoter-proximal pausing (PPP) on viral IE genes and controlling antisense transcription on the compact HSV-1 genome (13).
The current studies were undertaken to further clarify the roles of ICP4, ICP0, and ICP22 in early viral transcription. We used Precision nuclear Run On followed by deep Sequencing (PRO-Seq) to identify sites of Pol activity to base-pair resolution on the genomes of viruses bearing mutations in α0, α4, or α22, and corresponding viruses in which these loci were genetically restored.
RESULTS
In the absence of ICP4, Pol activity is dysregulated throughout HSV-1 infection.
We first used the ICP4 truncation mutant n12, derived from the KOS HSV-1 strain (14) to investigate the role of ICP4 during transcription. To allow comparison with virus that was otherwise genetically identical to the mutant, a repair virus was generated from n12 by recombination in infected cells with wild-type (WT) α4 DNA. Expression of full-length ICP4 was confirmed by immunoblotting (see Fig. S1A in the supplemental material). A single-step growth curve of the repair compared to n12 and WT HSV-1 (KOS) showed restored replication kinetics and high final yields relative to n12, with only slightly reduced replication compared to WT (Fig. S1B and C). HEp-2 cells were then infected at a multiplicity of infection (MOI) of 5.0 with either n12 or repaired virus, nuclei were harvested at 1.5, 3, or 6 h postinfection (hpi), and PRO-Seq was performed. HEp-2 cells harvested at 3 and 6 hpi were chosen for comparison to previous HSV-1 PRO-Seq studies (5, 13). We included the 1.5-hpi time point to measure transcription prior to the onset of viral DNA replication (5).
Visualization of the data on a genome browser revealed substantial differences in the pattern of Pol activity on the n12 genome from the repair genome (Fig. 1A, first panel). Consistent with the strict temporal expression of herpesvirus genes, Pol activity in the repair virus genome was restricted to IE genes at 1.5 hpi. In contrast, strong Pol activity was distributed across the entire n12 genome. At 3 hpi, the distribution of Pol activity on the two viral genomes was more similar, but activity on the pre-IE gene L/ST; the IE genes UL54 (α27), α4, α0, US1 (α22), and US12 (Fig. 1A, second panel); and many late genes remained higher in n12 than the repair. By 6 hpi, intense Pol activity of n12 was limited almost entirely to IE genes (and UL39), while activity on the repair virus genome was more evenly distributed among genes of all temporal classes (Fig. 1A, third panel).
FIG 1.
Dysregulated Pol activity throughout HSV-1 infection in the absence of ICP4. HEp-2 cells were infected with either the ICP4- mutant, n12, or its genetically restored repair, and PRO-Seq was performed at 1.5, 3, and 6 hpi. (A) Genome browser view of distribution of PRO-Seq reads (mean of 2 biological replicates, normalized to Drosophila spike-in) across the HSV-1 genome. External repeat sequences were deleted for the sequencing alignment. IE gene peaks are noted. (B) Log10-normalized read counts of all HSV-1 genes. The Mann-Whitney U test was used to estimate statistical significance. Log10-normalized read counts of immediate early (C), early (D), leaky late (E), and late (F) genes. Black diamonds indicate mean. Kruskal-Wallis test was performed to estimate statistical significance. ns, P > 0.05.
Quantification of sequencing reads aligning to individual HSV-1 genes confirmed a significant increase in Pol activity in n12 over the repair virus at 1.5 and 3 hpi (Fig. 1B). At 6 hpi, the total viral reads remained higher in n12, but this was due solely to intense IE gene activity (Fig. 1C) that did not occur in repair virus. Over time, activity on later gene classes of n12 (Fig. 1D to F) decreased, while in repair infection, Pol activity increased in all gene classes, except for IE genes between 3 and 6 hpi (Fig. 1C). Overall, these data indicate that ICP4 decreases Pol activity on all viral genes immediately after infection, and increases E, LL, and L activity later in infection.
PRO-Seq profiles of Pol occupancy on most HSV-1 genes follow that of cellular genes, with peaks at the 5′ PPP site and the 3′-cleavage poly(A) site (5). The promoters of the IE genes α4 and US1 showed clear PPP at all time points on the repair genome (Fig. 2A). High read counts on n12 IE genes obscured patterns of Pol activity on the same scale, so the browser was adjusted to a comparable read count depth between the two viruses. This revealed strong PPP on α4 and US1 throughout infection in n12. Other transcriptionally active regions in n12 lacked apparent PPP at 1.5 hpi, including E genes UL29 and UL30 (Fig. 2B), the LL genes UL18, UL19, and UL20, and the L genes UL20.5 and UL22 (Fig. 2C). The presence of a promoter peak was also assessed by examining the relative read density over a gene and using bootstrap confidence of fit to indicate statistical differences. To remove any uncertainty of whether a read was from a promoter region or gene body, only genes with no overlapping transcripts and with a defined transcription start site (TSS) were included in the analysis. We also separately analyzed genes that were robustly transcribed in repair infection at each time point, as it was assumed that these genes were transcribed in a temporally correct fashion. The set of appropriate positively regulated genes was determined by having a mean read per bp ≥1 standard deviation of mean and was termed “repair active.” Genes outside this set (i.e., that were transcribed robustly in n12 but not repair at a given time point) comprised a “repair-repressed” subset.
FIG 2.
Aberrant transcription on the HSV-1 genome at 1.5 hpi in the absence of ICP4. HEp-2 cells were infected with either the ICP4- mutant, n12, or its genetically restored repair, and PRO-Seq was performed at 1.5, 3, and 6 hpi. High-resolution genome browser view PRO-Seq tracks HSV-1 regions (mean of 2 biological replicates, normalized to Drosophila spike-in). (A) α4 and US1, shown scaled to equal sequencing depth and equal viral read counts; (B) UL28, UL29, and UL30; (C) UL18, UL19, UL20, UL20.5, UL21, and UL22. IE genes, red; E genes, pink; LL genes, blue; L genes, yellow. (D) Spline interpolation analysis of the relative distribution of reads across repair-active genes and repair-repressed genes. A closer view of the promoter region is also shown. The bootstrap confidence of fit is shown in the shaded area. (E) Proportion of reads mapping to the sense strand on all HSV-1 repair-active and repair-repressed genes. (F) Downstream read index of repair-active and repair-repressed genes. The Mann-Whitney U test was used to estimate statistical significance between viruses or gene sets at each time point. ns, P > 0.05. Repair active, genes that are robustly transcribed in both repair and mutant; repair repressed, genes that are robustly transcribed only in mutant.
Despite a large difference in total read counts on viral genes at 1.5 hpi, the distributions of reads across entire repair-active genes (i.e., relative read density) of n12 and repair were equivalent (Fig. 2D, top). Analysis of the promoter regions of active genes showed strong PPP on both viruses but with significantly higher PPP in n12 than in repair. A reduced but discernible promoter peak was visible on n12 repair-repressed genes. At 3 hpi, a similar pattern was seen (Fig. 2D, middle). When all genes in repair were included in the repair-active subset due to robust transcription at 6 hpi, both viruses had a similar pattern of read density across individual genes. Pause indices confirmed this trend and revealed that the patterns of pausing changed similarly throughout infection (Fig. S2A to C). These data indicate that the ICP4-mediated repression of most genes at IE times is due to a reduction in total Pol occupancy across entire genes rather than an increase in Pol pausing.
PRO-Seq visualization indicated extensive Pol activity on the antisense strands of genes in n12 at 1.5 hpi. To examine the regulation of sense-to-antisense transcription, the proportion of sense reads was calculated on isolated genes that lacked genes on the opposite strand. There was no significant difference in the levels of sense transcription between the two viruses in repair-active genes at 1.5 and 3 hpi, and both viruses had a high proportion of sense reads (Fig. 2E). However, the repair-repressed genes had a significant increase in antisense transcription at 1.5 and 3 hpi in n12. While n12 did have a significantly reduced global level of sense transcription at 6 hpi, this was largely due to high levels of antisense transcription on US8, US8A, US9, UL41, and UL56. Closer analysis of these regions revealed the presence of an upstream ICP4-independent promoter (US12, UL54, US1, and UL39) potentially driving read-through antisense Pol activity (Fig. S3A to D). This activity was also visible on the repair genome, indicating that it is a feature of HSV-1 transcription.
To determine whether detected intergenic Pol activity could be a result of read-through of a transcriptional termination signal (TTS) (AAUAA), a downstream read index was calculated by dividing the reads per bp 150 bp downstream of a TTS by the reads per base pair in the upstream open reading frame (ORF). For reads to be accurately assigned, only singular unnested genes with a defined TTS more than 150 bp away from a TSS were included. At 1.5 hpi, there was no significant difference in the downstream index on repair-active genes between n12 and repair (Fig. 2F). However, there was a significantly higher proportion of downstream transcription on repair-repressed genes at 1.5 hpi. By 3 and 6 hpi, there were no significant differences in intergenic transcription on the gene sets between viruses, suggesting proper termination was restored at these time points even in the absence of ICP4.
Overall, the PRO-Seq data at 3 and 6 hpi was consistent with ICP4 mutant phenotypes, primarily consisting of a failure to repress IE genes and to promote transcription of later gene classes (15, 16). However, the finding that ICP4 was required to repress Pol activity on virtually all viral genes at 1.5 hpi was unexpected. Pol activity on n12 IE genes was aberrantly high at 1.5 hpi, suggesting accelerated initiation. However, these genes displayed low levels of antisense and downstream transcription, and strong PPP peaks, suggesting that pausing and termination approached normal levels. In contrast, Pol activity on genes of later kinetic classes was indiscriminate and included antisense and intergenic transcription. Restoration of features consistent with proper termination and PPP returned in n12 by 3 and 6 hpi, indicating that proteins other than ICP4 act to improve transcriptional control after 1.5 hpi. Similar results as above were obtained in PRO-Seq experiments performed at 1.5 hpi of primary human foreskin fibroblasts (HFFs) showing that ICP4-mediated repression of viral transcription occurs in multiple cell types (Fig. S5A to F).
Virion-associated and de novo-expressed ICP4 are required for full transcriptional repression at 1.5 hpi.
We next asked whether the role of ICP4 to repress Pol early in infection required de novo protein synthesis or could be mediated by ICP4 entering the cell as a virion component. It should be noted that n12 virions do incorporate some ICP4 from the E5 cell line used to support n12 growth (17). HEp-2 cells were infected in the presence or absence of the protein synthesis inhibitor cycloheximide (CHX), followed by PRO-Seq at 1.5 hpi. Overall, CHX treatment led to a significant increase in reads aligning to viral genes on both the repair and n12 genome (Fig. 3A), indicating that de novo protein synthesis was required for full repression. However, Pol activity on the genes which reached the transcriptionally robust activity threshold (read per bp ≥1 standard deviation of the mean) was unaffected by CHX treatment in both virus infections. Moreover, the proportion of sense transcription on the repair-active genes in repair was unchanged by CHX treatment and was not reduced to the lower proportion seen across n12 (Fig. 3B).
FIG 3.
Both virion-associated and de novo-synthesized ICP4 are required for early transcriptional repression on the HSV-1 genome at 1.5 hpi. HEp-2 cells were infected with either the ICP4− mutant, n12, or its genetically restored repair in the presence or absence of the protein synthesis inhibitor cycloheximide (CHX) and PRO-Seq performed at 1.5 hpi. n = 2 for each treatment, normalized to Drosophila spike-in. (A) Mean read per base pair across HSV-1 genes; red genes indicate those that were defined as being robustly transcribed. (B) Proportion of reads mapping to the sense strand on repair-active and repair-repressed genes. (C) Scatterplot of HSV-1 gene reads after CHX treatment in repair and n12 infection. Shaded area indicates confidence prediction (mean ± standard error). DeSeq2 log2 fold change comparison of HSV-1 gene reads, separated by gene class of repair CHX treated relative to repair untreated (D) and n12 CHX treated relative to n12 untreated (E). IE, immediate early; E, early; LL, leaky late; L, late. Genes with a fold change-adjusted P value of ≤0.05 are shown in red. (F) PRO-Seq tracks of the HSV-1 α0-US1 IE gene region (mean of 2 biological replicates, normalized to Drosophila spike-in). Spline interpolation analysis of the relative distribution of reads across promoter regions in n12 repair repair-active genes (G), n12 repair-active genes (H), and n12 repair-repressed genes (I). The bootstrap confidence of fit is shown in the shaded area. Repair active, genes that are robustly transcribed in both repair and mutant; repair repressed, genes that are robustly transcribed only in mutant.
Correlation analysis of viral read counts between CHX treatment of n12 and repair revealed that CHX led to a relatively stronger increase of Pol activity on IE genes on n12 compared to repair (Fig. 3C). DeSeq2 (18) fold change analysis also revealed Pol activity on IE and pre-IE genes, especially L/ST, were only minimally affected by CHX treatment in repair (Fig. 3D). In contrast, CHX treatment in n12-infected cells led to a stronger increase on IE genes relative to other classes (Fig. 3E). Furthermore, we noted that the E and L genes of n12 that had significant increases in Pol activity were in genomic regions close to or nested with IE genes; (e.g., US10/11 nested with US12 and UL55 immediately downstream of UL54). These findings indicated that virion components in the repair virus retain the ability to repress much of the aberrant transcription that occurs in n12 infection. Previous reports have shown ICP4 to be a strong repressor of L/ST (19, 20) and therefore suggest ICP4 as the strongest candidate responsible for this repression. This was visible in the PRO-Seq data tracks since CHX treatment of repair yielded no visible increase in activity on L/ST and only negligible increases on the IE genes, α0, α4, and US1 (Fig. 3F). In contrast, CHX treatment of n12 led to extensive increases of Pol activity across all IE genes, indicating that n12 virion-associated proteins were insufficient to mediate full repression.
The PRO-Seq visualization also revealed strong PPP on IE genes in both n12 and repair (Fig. 3F). Spline interpolation analysis of the relative read density across genes indicated that in the presence of CHX, both n12 and repair had a significant reduction in PPP (Fig. 3G and H), suggesting that the increase in reads was at least partially due to increased release of Pol into the gene body. However, CHX did not alter PPP peaks on the repair-repressed genes of n12 (Fig. 3I). These data further suggest that proteins other than ICP4 must be synthesized to regulate early transcription and particularly to regulate PPP and release to elongation on IE genes.
The viral IE gene ICP22 is also involved in early Pol repression.
The previously characterized role of the IE gene ICP22 in the downregulation of Pol processivity and PPP enhancement (13) suggested a possible role for ICP22 in early HSV-1 Pol repression. To investigate this possibility, we used an ΔICP22 mutant virus lacking the entire US1 coding region and its genetically restored repair, which were derived from the HSV-1(F) strain (21, 22). HEp-2 cells were infected with the mutant, repair, or wild-type HSV-1(F) virus, and PRO-Seq was performed on nuclei harvested at 1.5 hpi.
ΔICP22 bore increased Pol activity across its genome compared to its genetically repaired counterpart at 1.5 hpi (Fig. 4A). We note that ΔICP22 repair had a significant increase in Pol activity relative to its parent wild-type strain HSV-1(F) virus. This may be attributed to the repair expressing relatively lower levels of IE proteins than WT (21) or to the secondary mutations in the BAC background, notably, the deletion of oriL (23). Nevertheless, ICP22 clearly played an important role in repression inasmuch as activity was significantly lower in the ΔICP22 repair virus than in the congenic ΔICP22 mutant (P < 0.0001) (Fig. 4B). The overall difference in reads was not as great as between n12 ICP4− and its repair (Fig. S5), but the pattern of Pol activity across the ΔICP22 genome as viewed by IGV was strikingly similar to n12 and covered the entire genome on both strands, a pattern distinct from repair and WT.
FIG 4.
Aberrant viral transcription at 1.5 hpi in the absence of ICP22. HEp-2 cells were infected with a ΔICP22 mutant, its genetically restored repair and WT (F) and PRO-Seq performed at 1.5 hpi. (A) Genome browser view of distribution of PRO-Seq reads (data are mean of 3 biological replicates normalized to Drosophila spike-in) across the HSV-1 genome. External repeat sequences were deleted for the sequencing alignment. (B) Log10-normalized read counts of all HSV-1 genes. High-resolution genome browser view PRO-Seq tracks HSV-1 regions are α4 and US1 (C) and UL28, UL29, and UL30 (D). IE genes, red; E genes, pink; LL genes, blue. (E) Proportion of reads mapping to the sense strand on repair-active genes. (F) Downstream read index of repair-active and repair-repressed genes. The Mann-Whitney U test was used to estimate statistical significance between mutant/repair or gene sets. ns, P > 0.05. (G) Spline interpolation analysis of the relative distribution of reads across repair-active and -repressed genes. A closer view of the promoter region is also shown. The bootstrap confidence of fit is shown in the shaded area. (H) Pause index values of repair-active and repair-repressed genes. Data are mean ± standard error. An unpaired Student’s t test was used to estimate statistical significance between mutant and repair on each gene. Repair active, genes that are robustly transcribed in both repair and mutant; repair repressed, genes that are robustly transcribed only in mutant.
Examples of dysregulated transcription were visible throughout the ΔICP22 genome. For example, Pol activity was increased at the α4/US1 region (Fig. 4C) and over the E genes UL29 and UL30 (which are not normally active at 1.5 hpi) (Fig. 4D). PRO-Seq patterns at these regions were inconsistent with properly regulated transcription with extensive antisense and intergenic transcription on the ΔICP22 genome and an apparent lack of PPP. The increase in antisense activity at 1.5 hpi was significant across all genes (Fig. 4E), indicating ΔICP22 lacked regulation of sense-to-antisense transcription across the entire genome. Downstream read index calculations also indicated a deficiency in transcriptional termination of the ΔICP22 virus, with significantly increased levels of reads downstream of the TTS on the repair-repressed genes (Fig. 4F). ΔICP22 also had a significant reduction in the promoter-proximal peak on repair-active genes and an almost complete lack of this peak on repair-repressed genes at 1.5 hpi (Fig. 4G). This reduced PPP was confirmed by pause-index analyses (Fig. 4H). The lack of PPP on IE genes was reminiscent of the ΔICP22 phenotype noted previously at 3 hpi (13).
We previously showed that virion-associated ICP4 is required for full early transcriptional repression (Fig. 3). However, ICP22 is not known to be virion associated (7), suggesting that ICP22 must be synthesized rapidly de novo to help suppress viral transcription. In order to investigate this possibility, we repeated the PRO-Seq experiment in the presence or absence of CHX. A small but significant increase occurred in reads across viral genes on both ΔICP22 and repair genomes after CHX treatment (Fig. 5A). However, the level of activity on genes classified as being robustly transcribed (read per bp ≥1 standard deviation of the mean) did not change after treatment, indicating that the overall distribution of Pol across the viral genome was unchanged. This can be seen in the IGV visualization in Fig. 5B, with the repair retaining most of its Pol activity on IE genes. Further indication that the CHX treatment of the repair did not phenocopy the unrepressed ΔICP22 phenotype was indicated by the lack of effect on the proportion of sense transcription on the repair-active genes and a failure to lower sense transcription on the repair genome to the low level seen across the ΔICP22 mutant genome (Fig. 5C).
FIG 5.
ICP22 is synthesized by 1.5 hpi to regulate PPP on IE genes. HEp-2 cells were infected with ΔICP22 mutant or its genetically restored repair in the presence or absence of the protein synthesis inhibitor cycloheximide (CHX) and PRO-Seq performed at 1.5 hpi. n = 2 for each treatment, normalized based on total library read counts. (A) Mean read per base pair across HSV-1 genes; red genes indicate those that were defined as being robustly transcribed. (B) Genome browser view of distribution of PRO-Seq reads across the HSV-1 genome; IE genes are indicated. (C) Proportion of reads mapping to the sense strand on repair and repair-repressed genes. DeSeq2 log2 fold change comparison of HSV-1 gene reads, separated by gene class of repair CHX treated relative to repair untreated (D) and ΔICP22 CHX treated relative to ΔICP22 untreated (E). IE, immediate early; E, early; LL, leaky late; L, late. Genes with a fold change-adjusted P value of ≤0.05 are shown in red. (F) Scatterplot of HSV-1 gene reads after CHX treatment in repair and ΔICP22 infection. Shaded area indicates confidence prediction (mean ± standard error). Spline interpolation analysis of the relative distribution of reads across promoter regions in repair-active genes (G), ΔICP22 repair-active genes (H), and ΔICP22 repair-repressed genes (I). The bootstrap confidence of fit is shown in the shaded area. Repair active, genes that are robustly transcribed in both repair and mutant; repair-repressed, genes that are robustly transcribed only in mutant.
DeSeq2 fold change analysis indicated that the read increases were not specific to a particular gene or class (Fig. 5D and E). Consistent with CHX treatment of n12 repair (Fig. 3D), IE genes were only minimally affected in the ΔICP22 repair, supporting the suggestion that virion components primarily repress transcription of these genes. Interestingly, correlation analysis of viral read counts between CHX treatment of ΔICP22 and repair revealed that CHX led to a stronger increase in IE genes (or those nested with IE genes) on repair relative to ΔICP22 (Fig. 5F), indicating virion components in ΔICP22 are more effective at repressing IE gene transcription. CHX treatment led to reduced PPP on repair-active genes on the repair (Fig. 5G) but did not alter the already reduced PPP on either repair-active or repair-repressed ΔICP22 genes (Fig. 5H and I). Overall, these data suggest that ICP22 is required to be rapidly synthesized by 1.5 hpi in order to regulate PPP on IE genes at early time points.
Viral IE gene ICP0 is also required for early Pol repression.
The CHX experiments have indicated that incoming proteins in wild-type virions are sufficient to repress much of the aberrant transcription that occurs early in infection with IE mutants. Aside from ICP4, ICP0 is the only other known IE gene present in the virion (7). Therefore, we performed PRO-Seq in HEp-2 cells infected with HSV-1 n212, which contains a nonsense mutation in α0 derived from the KOS HSV-1 strain (24). To ensure the ICP0 control virus had a genetically identical background to the mutant, a repair virus was generated by recombination with α0 DNA. Immunoblotting was used to confirm repair of the ICP0 locus (Fig. S1D), and single-step growth curve analysis showed comparable replication kinetics and final yield of the repair relative to WT KOS (Fig. S1E and F). HEp-2 cells were infected with n212 or repair, and PRO-Seq was performed on nuclei harvested at 1.5 hpi.
As with n12 and ΔICP22, infection with n212 led to a statistically significant (P < 0.0001) increase in viral reads relative to repair (Fig. 6A). The most striking difference in PRO-Seq profiles between n212 and its repair was an increase in activity on repair repressed genes at this early time point. For example, the E genes UL29 and UL30 are not normally active at 1.5 hpi (as visible in repair) but bore substantial Pol activity on the n212 genome. However, the pattern of transcriptional activity more closely approximated that of normal regulation, with activity limited to ORFs and not covering the entire genome (Fig. 6B), as was seen in n12 and ΔICP22. For example, the PRO-Seq pattern of IE genes α4 and US1 included prominent PPP peaks and minimal antisense/intergenic activity (Fig. 6C). Even genes such as UL29 and UL30 that were aberrantly active in n212 displayed features indicative of proper transcriptional reregulation (Fig. 6D). Spline interpolation analysis confirmed that promoter peaks on repair-active genes in n212 were unchanged relative to repair and repair-repressed genes also maintained a PPP peak (Fig. 5E).
FIG 6.
The absence of ICP0 leads to increased transcriptional activity on the HSV-1 genome at 1.5 hpi. (A) Log10-normalized PRO-Seq read counts of HSV-1 genes at 1.5 hpi postinfection with n212 ICP0− mutant and its genetically restored repair (n = 2, normalized to Drosophila spike-in). The Mann-Whitney U test was used to estimate statistical significance between mutant and repair. (B) Genome browser view of distribution of PRO-Seq reads across HSV-1 genome at 1.5 hpi. High-resolution genome browser view PRO-Seq tracks HSV-1 regions α4 and US1 (C) and UL28, UL29, and UL30 (D). IE genes, red; E genes, pink; LL genes, blue. (E) Spline interpolation analysis of the relative distribution of reads across repair-active and -repressed genes. A closer view of the promoter region is also shown. The bootstrap confidence of fit is shown in the shaded area. (F) Proportion of reads mapping to the sense strand on repair-active and repair-repressed genes. (G) Downstream read index of repair-active and repair-repressed genes. (H) DeSeq2 log2 fold change comparison of HSV-1 gene reads at 1.5 hpi of ICP0− mutant n212 infected relative to repair infected. (I) Genome browser view of distribution of PRO-Seq reads across the HSV-1 genome at 3 and 6 hpi. The Mann-Whitney U test was used to estimate statistical significance between viruses or gene sets at each time point. ns, P > 0.05. Repair active, genes that are robustly transcribed in both repair and mutant; repair repressed, genes that are robustly transcribed only in mutant.
Quantification of sense/antisense transcription revealed that n212 had almost identical levels of sense transcription to repair on repair-active genes (Fig. 6F). There was a reduced proportion of sense transcription on the repair-repressed gene set, but the proportion of sense transcription was higher than either n12 or ΔICP22. In addition, antisense transcription occurred heavily on US8, US8A, US9, and UL41, which bore high levels of antisense transcription in n12 and its repair (at 3 and 6 hpi) (Fig. 2F), further indicating that the antisense activity on these genes is a consistent feature of active HSV-1 transcription. In contrast to n12 and ΔICP22, downstream read index calculations indicated that n212 retained normal transcriptional termination even on repair-repressed genes (Fig. 6G).
DeSeq2 analysis of individual genes indicated that n212 displayed the strongest increases in activity on specific E genes (Fig. 6H). There was no apparent trend for upregulation of a specific gene class over others in either n12 or ΔICP22 (Appendix S2). One interpretation of these data is that in the absence of ICP0, transcription progresses more rapidly through the temporal transcriptional program, causing later genes to be transcribed earlier. PRO-Seq data using n212 at 3 and 6 hpi were consistent with this hypothesis inasmuch as the distribution of Pol across the genome in n212 at 1.5 hpi matched that of the repair at 3 hpi (Fig. 6I). By 6 hpi, n212 and its repair had virtually matching PRO-Seq profiles, although n212 continued to have higher read counts. This result differed from ΔICP22, which had reduced Pol activity on IE genes at 3 hpi and loss of Pol activity from most genes by 6 hpi (13), and n12, which primarily retained activity on only IE genes at 3 and 6 hpi (Fig. 1).
To determine whether the increased PRO-Seq reads during infection with IE gene mutants were a result of increased genome copies entering the nucleus, we used quantitative PCR (qPCR) to quantify viral DNA levels in isolated nuclei at 1.5 hpi. All mutants did have increased numbers of incoming genomes relative to their congenic repairs (Fig. S5). However, the increased genome copies could not fully account for the increase in PRO-Seq reads aligning with the mutant viral genomes. Therefore, much of the increased transcriptional activity of the mutants was attributable to repression mediated by the respective IE genes rather than changes in particle infectivity.
DISCUSSION
We have shown that ICP0, ICP4, and ICP22 are individually required for early transcriptional repression on the HSV-1 genome that precedes the activation of the temporal transcriptional cascade. High Pol activity might be expected early in infection because HSV-1 genomes enter the nucleus free of nucleosomes and contain densely packed, mostly intron-less genes encoded on both strands. This gene arrangement necessitates a high concentration of promoter elements, such as TATA boxes and initiator sequences recognized by cellular Pol (25, 26), and multiple GC-rich regions that can bind cellular transcription factors, including Sp1 and Egr-1 (27, 28). In addition, VP16 cointroduced with the genome is a powerful transcription factor with potent DNA binding activity for viral IE promoters and a transcriptional activation domain (TAD) that interacts with many transcription factors such as TFIIA, TFIIB, TBP, and TFIIH (29). The effectiveness of these elements is supported by the observation that by 3 h after infection, the viral genome bears one-third of all Pol activity of the cell (30).
It is likely that the newly introduced HSV-1 genome is rapidly engaged by not only virion-delivered VP16, ICP0, and ICP4 but also by cellular histones. Previous studies have shown that histones associate with the viral genome during lytic infection (reviewed in reference 31) and that histone dynamics are important in the regulation of lytic transcription (32). Other studies emphasize the ability of ICP4 to coat the viral genome in a form of “viral chromatin” (33). ICP4 in this viral chromatin was proposed to facilitate recruitment of Pol and components of the preinitiation complex. However, because Pol is efficiently recruited to the viral genome in the absence of full-length ICP4 (and ICP0 and ICP22), we propose that a major function of ICP4 and virally orchestrated chromatin is to transiently repress transcription.
The repressive role of ICP4 is consistent with ICP4’s known ability to repress IE gene transcription and was supported by our 6-hpi PRO-Seq data in which n12 was unable to repress IE gene Pol activity. ICP4 repression is associated with ICP4-binding sites (19, 20, 34) that have a relatively loose consensus sequence with more than 100 copies throughout the viral genome (33). CHX treatment showed that virion-associated ICP4 represses IE genes preferentially. This may seem paradoxical since the tegument also contains the major IE transcriptional activator, VP16 (2), but further highlights the intricate balance of control the virus exerts over its own transcription.
It is possible that early transcriptional repression is dependent on the form of ICP4, which must switch from a repressor to an activator on certain genes at certain times. n12 is not completely null for ICP4 and expresses a truncated form (see Fig. S1A in the supplemental material), containing most of the N-terminal activation domain but lacking the DNA-binding domain (35). The N-terminal domain has been shown to be required for viral gene activation through interactions with TFIID and mediator (36). Therefore, the abundant transcription in n12 at 1.5 hpi may be due to this truncated form of ICP4 recruiting transcription factors and its inability to form a complex with TFIIB and TBP, which is believed to foster repression (37).
The result with ΔICP22 likely reflects ICP22’s known role in reducing processivity of RNA polymerase (13), yet it was surprising that this occurred over the entire viral genome and was not limited to IE genes. One possible explanation is that transcription is initiated at VP16 sites but that the increased Pol processivity in the absence of ICP22 leads to substantial read-through into neighboring genes (38). ΔICP22 mutant virions have a defect in virion composition (39), including an increase in ICP4, and could also therefore contain an increased level of VP16. This increase in ICP4 may also explain why the ΔICP22 mutant was more effective at IE repression than its repair (Fig. 5F) and support the finding that tegument ICP4 primarily functions to repress IE gene transcription. ICP22 has also been shown to interact with several elongation regulatory factors, including FACT (40), p-TEFb (41), and CDK9 (42), and it has been proposed that these interactions lead to selective repression of cellular genes (43). A similar mechanism might account for repression of the HSV-1 genome early in infection.
We also noted an increase in early transcription in cells infected with the α0 mutant n212. ICP0 is enriched in ICP22 mutant virions (39) and has an increased association with n12 genomes relative to WT (17). While ICP0 functions as a promiscuous transactivator that acts by causing degradation of cellular transcriptional silencing factors (44), PRO-Seq of cells infected with n212 unexpectedly exhibited increased transcriptional activity at 1.5 hpi. Unlike the ICP4 and ICP22 mutants, the pattern of Pol activity on the ICP0 mutant genome reflected normal regulatory features. It is known that ICP0 mutants infected at high MOIs grow equivalently to wild-type virus (44) (this can be seen in Fig. S1F) and that these mutants produce a large number of defective particles at very early stages of infection (24). One possibility is that the large number of defective particles deliver more abundant virion components, such as the incoming VP16/ICP4, to help activate the n212 genome. Our CHX experiments also highlighted the importance of virion components in early transcriptional repression.
HSV-1 forms membrane-less liquid-like transcriptional condensates (45), and ICP4 has been identified as an important factor in their formation (46). It is possible that these condensates act to protect the viral genome from unregulated transcription. Promyelocytic leukemia nuclear bodies (PML NBs, or ND10) are also liquid-like membrane-less organelles. ND10 components rapidly associate with incoming HSV-1 genomes, presumably to repress infection (47), and are usually targeted for proteasomal degradation by ICP0. Disruption of IE gene expression may alter the formation of these condensates, impairing recruitment of repressors to the viral genome and leading to unfettered exposure to the cellular transcriptional machinery, resulting in rampant Pol activity.
The lack of transcriptional regulation across most of the n12 and ΔICP22 genomes at 1.5 hpi suggests that cotranscriptional processing events are also disrupted (38). Consequently, it is likely that the RNA generated is not processed into mature mRNA, though this remains to be determined. The large amount of RNA being produced is a potential trigger for antiviral responses and indicates why rampant transcription is likely disadvantageous to a virus such as HSV-1. This is supported by the finding that both n12 and ΔICP22 act to repress this aberrant transcription by 3 and 6 hpi. We propose that the timing of this repression may explain some of the differences between experiments. For example, the overall read difference between n12 and repair was less extensive when repeating the experiment with CHX and in HFF cells, suggesting the virus had begun to gain control of transcription already. The fact that the unrepressed phenotype was strongest at just 1.5 hpi likely explains why this process has not been previously identified. Furthermore, we were only able to identify the requirement for early transcriptional repression by comparison to ICP4 and ICP22 mutants, which other HSV-1 nascent transcriptome sequencing (4SU labeling) studies did not include (48). We also note that PRO-Seq identifies nascent transcription that does not necessarily correlate with mature mRNA accumulation. Therefore, mRNA-Seq studies (6) would not necessarily identify the increased Pol activity shown here.
Because each IE protein affects production of the others, we cannot currently determine whether the observed derepression was due to the specific loss of one, or a combinatorial effect, and the full mechanism of repression remains to be elucidated. Nevertheless, we have shown that prior to initiating activation of transcription, IE genes first mediate transcriptional repression. This is a previously unrecognized process preceding steps outlined in the current paradigm of HSV transcription, which proposes that IE gene products function primarily to promote viral gene expression (49). These data suggest that the current paradigm be modified to consider the entire cascade of viral gene expression as a series of derepression steps on different genes. Transient repression may represent an important checkpoint for a virus that can orchestrate one of two potential transcriptional programs, one that is robust during productive replication in which repression is reversed or, one during latency in which repression is maintained.
MATERIALS AND METHODS
Cells.
HEp-2 (human epithelial lung cancer), Vero (African green monkey), RSC (rabbit skin), and the Vero-derived ICP4-complementing E5 cells (14) were maintained in Dulbecco’s modified Eagle’s medium (DMEM) containing 10% newborn calf serum (NBS), 100 units/mL penicillin, and 100 μg/mL streptomycin (Pen-Strep) and maintained at 37°C with 5% CO2. U2OS (human bone osteosarcoma) cells were maintained in McCoy’s 5A medium containing 10% fetal bovine serum (FBS) and Pen-Strep and maintained at 37°C with 5% CO2. Human foreskin fibroblasts (HFFs) were maintained in DMEM containing 15% FBS and Pen-Strep at 37°C with 5% CO2. S2 (Drosophila melanogaster) cells were grown in Schneider’s medium containing 10% FBS and maintained at 23°C. E5 cells were a gift from Neal DeLuca, University of Pittsburgh, and HFF cells were a gift from Luis Schang, Cornell University.
Viruses.
Mutant HSV-1 strains n12 (14) and n212 (24), both HSV-1 KOS derived, were gifts from Neal DeLuca, University of Pittsburgh. n12 virus stocks were prepared on E5 cells, and n212 stocks were prepared on U2OS cells. The ΔICP22 virus and its repair, generated from an HSV-1(F) bacterial artificial chromosome, were gifts from Yasushi Kawaguchi (21, 22). Stocks were prepared on Vero cells.
Repair viruses of n12 (α4 mutant) and n212 (α0 mutant) were generated through homologous recombination. Plasmids containing WT HSV-1 DNA spanning 1,000 bp on either side of the mutation were synthesized, linearized, and then transfected using TransIT-X2 (Mirus Bio) into RSC cells. Six hours after transfection, cells were infected at an MOI of 1 with the corresponding mutant, and when all cells showed cytopathic effect (CPE), they were harvested by scraping into media. Viruses were released from cells through 3× cycles of freeze-thaw in LN2 and 37°C water bath. Samples were then serially diluted onto Vero cells with an agarose overlay and underwent 3 rounds of plaque purification. Repair virus plaques were selected by size due to the growth restriction of the mutants on Vero cells. Western blotting was used to confirm successful repair of full-length protein expression (see Fig. S1 in the supplemental material). Stocks were subsequently prepared on Vero cells.
Virus infections and drug treatments.
For assessment of IE protein expression, monolayers of HEp-2 cells were infected with HSV-1 at an MOI of 5 in 199V medium (plus 1% NBS). After 1 h, the inoculum was replaced with DMEM (plus 2% NBS).
For PRO-Seq, monolayers of HEp-2 cells were infected with HSV-1 at an MOI of 5 as described above. Infections were allowed to continue for 1.5, 3, or 6 hpi (hpi refers to the time after the viral inoculum was first added to cells). For CHX treatments, 10 μm of CHX was added to media 1 h prior to infection, and this CHX concentration was maintained in the media throughout infection.
Single-step growth curve analysis.
Monolayers of HEp-2 cells were infected with HSV-1 at an MOI of 5 in 199V medium (plus 1% NBS) at 37°C. After 1 h, inoculum was removed, cells were washed 3× in phosphate-buffered saline (PBS) to remove unabsorbed virus, and DMEM (with 2% NBS) was added. Infected cells were harvested at 0, 6, 12, 18, and 24 hpi by scraping into media, and viruses were released from cells by 3× cycles of freeze-thaw in LN2 and 37°C water bath. Virus yields were determined by plaque assay on Vero cells or appropriate complementing cell line.
Western blotting.
Lysates were prepared from infected cells by washing cells 2 times in ice-cold PBS before addition of an appropriate volume of NP-40 lysis buffer (150 mM NaCl, 1% NP-40, 50 mM Tris, pH 8, and protease inhibitors). Cells were then scraped into suspension and incubated on ice for 30 min. Twenty micrograms of protein was mixed with 2× protein sample loading buffer (Li-Cor) and heated to 98°C for 5 min. Samples were separated on an 8% polyacrylamide resolving gel and layered with a 5% stacking gel. Proteins were transferred to a 0.45-μm nitrocellulose membrane using a wet transfer technique. Membranes were first blocked for 1 h at room temperature in 5% bovine serum albumin (BSA) with 0.1% Tween 20 and then incubated with the primary antibodies diluted in blocking buffer at 4°C overnight. Membranes were washed 4× for 5 min in PBS containing 0.1% Tween 20 (PBS-T) before being incubated with the secondary antibodies diluted in blocking buffer at room temperature for 45 min. Membranes underwent a further 4× of 5-min washes in PBS-T and were then visualized on an Odyssey scanner (Li-Cor). Primary antibodies were anti-ICP4 (catalog no. sc-69809; Santa Cruz), used at 1:200, and anti-ICP0 (catalog no. sc-53070; Santa Cruz), used at 1:100. Secondary antibodies were DyLight 680 and 800 (Cell Signaling).
Nuclei isolation and PRO-Seq.
Nuclei were isolated from infected cells, nuclear run-on with biotinylated nucleotides performed, and sequencing libraries were generated as described previously (5, 13, 30, 50). Nuclei from D. melanogaster S2 cells were spiked into infected cell nuclei at a ratio of 1:1,000 prior to run-on. Libraries were sequenced on an Illumina NextSeq 500, performed by the GeneLab at Louisiana State University School of Veterinary Medicine or by the Biotechnology Resource Center (BRC) Genomics Facility (RRID SCR_021727) at the Cornell Institute of Biotechnology.
DNA isolation.
The lower interphase and organic layers of TRIzol LS RNA-extracted HEp-2 infected nuclei were saved. The DNA was subsequently isolated following the manufacturer’s protocol for TRIzol DNA isolation (Invitrogen; publication no. MAN0016385). To clean up the isolated DNA, 3× phenol-chloroform-isoamyl alcohol purification was performed before ethanol precipitation using sodium acetate. DNA was resuspended in diethyl pyrocarbonate (DEPC) water.
Quantitative PCR for viral genome copy.
Extracted DNA was quantified using NanoDrop spectrophotometer (Thermo Scientific). HSV-1 genome copy number was determined in 50 ng of extracted DNA by qPCR as previously described (5, 30) using Brilliant III SYBR Green master mix with ROX (Agilent); and analysis was performed using QuantStudio 3 (Applied Biosystems).
Read processing.
FastQ files were processed using the PRO-Seq pipeline developed by the Danko lab (Cornell) (https://github.com/Danko-Lab/utils/tree/master/proseq). Reads were aligned to a concatenated genome file containing hg38, dm3, and HSV-1 genomes. HSV-1 genome builds had the external repeats deleted to aid sequencing alignment; the modified genome files are available at https://github.com/Baines-Lab/Public/tree/main/HSV-1. SeqMonk software (51) was used to probe reads from the individual genomes in the output BAM files. Drosophila spike-in normalization was used to account for variation in sequencing depth between libraries. Libraries were normalized relative to the library with the largest Drosophila read count, with the scale factor for this set to 1. Libraries prepared without spike-in were normalized based on total library read counts. The output .bw files (containing only the 3′ final read position) were visualized using the IGV genome browser (52). Individual reads for each bp across the HSV-1 genome were extracted from the .bw files using multiBigWigSummary from deepTools (53) and normalized as above. The resulting .txt files were used for analysis in SeqMonk or BedGraph for visualization in IGV. The normalized .txt and .bedGraph files were used for all subsequent data analysis.
Identification of transcriptionally active genes.
The robust transcription threshold to identify repair-active genes was determined on data from repair virus infection at 1.5 hpi due to restricted transcriptional activity on these samples. Genes were classified to be transcriptionally active (repair active) if the mean read per base pair (TSS-TTS) was greater than 1 standard deviation of the mean of all genes. Genes below this threshold in repair infections, but those above this threshold in mutant infections were classified as repair repressed. The same threshold was used at all time points and was calculated individually for each sequencing experiment due to variation in sequencing depth. Details of normalized HSV-1 gene reads, reads per base pair, and robust transcription thresholds are given in Appendix S1.
Promoter proximal pause analysis.
The relative distribution of reads across gene sets was determined using the SeqMonk probe trend plot on .txt files. Genes were divided into 100 bins to get relative distance across genes. Data were plotted using the smoother function in SAS JMP Pro software, and the bootstrap confidence of fit was calculated using 300 iterations of the data. Pause index calculations for individual genes were determined by the following formula: mean read per bp (TSS + 150 bp)/mean read per bp of rest of gene (to TTS). Only viral genes with no overlapping transcripts and with a defined TSS were included in PPP analysis to allow reads to be accurately assigned.
Sense transcription proportion calculation.
The proportion of sense transcription on each HSV-1 gene was calculated by the following formula: reads of sense strand of gene (TSS-TTS)/reads of antisense strand of gene (TSS-TTS). Only isolated HSV-1 genes without genes on the opposite strand were included in the final analysis to allow reads to be accurately assigned. Regression analysis was used to assess the correlation between sense proportion and read per bp (TSS-TTS) of each HSV-1 gene. The square of the correlation coefficient (R2) was calculated using SAS JMP Pro software.
Downstream read index calculation.
The level of reads downstream of TTS was calculated by the following formula: reads per bp 150 bp downstream of TTS/reads per bp in upstream ORF (TSS-TTS). Only singular unnested genes with a defined TTS more than 150 bp away from any other TSS were included to allow reads to be accurately assigned.
Fold change analysis.
Fold change analysis was performed using the R package DeSeq2 (18). DeSeq2 for HSV-1 genes was performed incorporating Hg38 genes data to account for the library size correction step. Full DeSeq2 fold change and P values are given in Appendix S2.
Statistical analysis.
Statistical significance was determined by unpaired Student’s t test for pairwise comparisons of normally distributed data, the Mann-Whitney U test was used for pairwise comparison of nonparametric data, and the Kruskal-Wallis was used for multiple comparisons. Calculations were performed using SAS JMP Pro software. Each independent experiment consisted of 2 to 3 biological replicates.
Data availability.
The data is available on the GEO database under the accession numbers GSE202363 and GSE213098.
ACKNOWLEDGMENTS
We thank Neal DeLuca, Luis Schang, and Yasushi Kawaguchi for their kind gifts of cells and viruses. We thank Thaya Stoufflet and Vladimir Chouljenko at the LSU SVM GeneLab and the Genomics Facility (RRID SCR_021727) of the Biotechnology Resource Center of Cornell Institute of Biotechnology for their help with sequencing experiments. Portions of this research were conducted with the high-performance SuperMic supercomputer provided by Louisiana State University (http://www.hpc.lsu.edu). We thank Le Yan for his help in maintaining the PRO-Seq pipeline.
These studies were supported by National Institutes of Health grants R01 AI 141968 and R21 AI 148926 to J.D.B.
J.D.B. conceived the study; L.E.M.D. performed experiments involving n12 and n212 HSV-1 viruses. C.H.B. and R.D. performed experiments involving ΔICP22 HSV-1. L.E.M.D. performed data analysis and made the figures. All authors discussed results. L.E.M.D. and J.D.B. wrote and edited the manuscript.
Footnotes
Supplemental material is available online only.
Contributor Information
Joel D. Baines, Email: jdb11@cornell.edu.
Lori Frappier, University of Toronto.
REFERENCES
- 1.Honess RW, Roizman B. 1974. Regulation of herpesvirus macromolecular synthesis. I. Cascade regulation of the synthesis of three groups of viral proteins. J Virol 14:8–19. 10.1128/JVI.14.1.8-19.1974. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 2.Ibáñez FJ, Farías MA, Gonzalez-Troncoso MP, Corrales N, Duarte LF, Retamal-Díaz A, González PA. 2018. Experimental dissection of the lytic replication cycles of herpes simplex viruses in vitro. Front Microbiol 9:2406–2406. 10.3389/fmicb.2018.02406. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 3.Johnson KM, Mahajan SS, Wilson AC. 1999. Herpes simplex virus transactivator VP16 discriminates between HCF-1 and a novel family member, HCF-2. J Virol 73:3930–3940. 10.1128/JVI.73.5.3930-3940.1999. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 4.O'Hare P, Goding CR. 1988. Herpes simplex virus regulatory elements and the immunoglobulin octamer domain bind a common factor and are both targets for virion transactivation. Cell 52:435–445. 10.1016/S0092-8674(88)80036-9. [DOI] [PubMed] [Google Scholar]
- 5.Birkenheuer CH, Baines JD. 2020. RNA polymerase II promoter-proximal pausing and release to elongation are key steps regulating herpes simplex virus 1 transcription. J Virol 94:e02035-19. 10.1128/JVI.02035-19. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 6.Harkness JM, Kader M, DeLuca NA. 2014. Transcription of the herpes simplex virus 1 genome during productive and quiescent infection of neuronal and nonneuronal cells. J Virol 88:6847–6861. 10.1128/JVI.00516-14. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 7.Loret S, Guay G, Lippé R. 2008. Comprehensive characterization of extracellular herpes simplex virus type 1 virions. J Virol 82:8605–8618. 10.1128/JVI.00904-08. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 8.DeLuca NA, McCarthy AM, Schaffer PA. 1985. Isolation and characterization of deletion mutants of herpes simplex virus type 1 in the gene encoding immediate-early regulatory protein ICP4. J Virol 56:558–570. 10.1128/JVI.56.2.558-570.1985. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 9.Rivera-Gonzalez R, Imbalzano AN, Gu B, Deluca NA. 1994. The role of ICP4 repressor activity in temporal expression of the IE-3 and latency-associated transcript promoters during HSV-1 infection. Virology 202:550–564. 10.1006/viro.1994.1377. [DOI] [PubMed] [Google Scholar]
- 10.Rivas T, Goodrich JA, Kugel JF. 2021. The herpes simplex virus 1 protein ICP4 acts as both an activator and a repressor of host genome transcription during infection. Mol Cell Biol 41:e0017121. 10.1128/MCB.00171-21. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 11.Gu H, Roizman B. 2007. Herpes simplex virus-infected cell protein 0 blocks the silencing of viral DNA by dissociating histone deacetylases from the CoREST–REST complex. Proc Natl Acad Sci USA 104:17134–17139. 10.1073/pnas.0707266104. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 12.Fraser KA, Rice SA. 2005. Herpes simplex virus type 1 infection leads to loss of serine-2 phosphorylation on the carboxyl-terminal domain of RNA polymerase II. J Virol 79:11323–11334. 10.1128/JVI.79.17.11323-11334.2005. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 13.Birkenheuer CH, Dunn L, Dufour R, Baines JD. 2022. ICP22 of herpes simplex virus 1 decreases RNA polymerase processivity. J Virol 96:e02191-21. 10.1128/jvi.02191-21. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 14.DeLuca NA, Schaffer PA. 1988. Physical and functional domains of the herpes simplex virus transcriptional regulatory protein ICP4. J Virol 62:732–743. 10.1128/JVI.62.3.732-743.1988. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 15.Dixon RA, Schaffer PA. 1980. Fine-structure mapping and functional analysis of temperature-sensitive mutants in the gene encoding the herpes simplex virus type 1 immediate early protein VP175. J Virol 36:189–203. 10.1128/JVI.36.1.189-203.1980. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 16.Watson RJ, Clements JB. 1980. A herpes simplex virus type 1 function continuously required for early and late virus RNA synthesis. Nature 285:329–330. 10.1038/285329a0. [DOI] [PubMed] [Google Scholar]
- 17.Dembowski JA, DeLuca NA. 2018. Temporal viral genome-protein interactions define distinct stages of productive herpesviral infection. mBio 9:e01182-18. 10.1128/mBio.01182-18. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 18.Love MI, Huber W, Anders S. 2014. Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2. Genome Biol 15:550. 10.1186/s13059-014-0550-8. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 19.Lee LY, Schaffer PA. 1998. A virus with a mutation in the ICP4-binding site in the L/ST promoter of herpes simplex virus type 1, but not a virus with a mutation in open reading frame P, exhibits cell-type-specific expression of gamma(1)34.5 transcripts and latency-associated transcripts. J Virol 72:4250–4264. 10.1128/JVI.72.5.4250-4264.1998. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 20.Yeh L, Schaffer PA. 1993. A novel class of transcripts expressed with late kinetics in the absence of ICP4 spans the junction between the long and short segments of the herpes simplex virus type 1 genome. J Virol 67:7373–7382. 10.1128/JVI.67.12.7373-7382.1993. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 21.Maruzuru Y, Fujii H, Oyama M, Kozuka-Hata H, Kato A, Kawaguchi Y. 2013. Roles of p53 in herpes simplex virus 1 replication. J Virol 87:9323–9332. 10.1128/JVI.01581-13. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 22.Maruzuru Y, Shindo K, Liu Z, Oyama M, Kozuka-Hata H, Arii J, Kato A, Kawaguchi Y. 2014. Role of herpes simplex virus 1 immediate early protein ICP22 in viral nuclear egress. J Virol 88:7445–7454. 10.1128/JVI.01057-14. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 23.Roller RJ, Hassman T, Haugo-Crooks A. 2021. Cell culture evolution of a herpes simplex virus 1 (HSV-1)/varicella-zoster virus (VZV) UL34/ORF24 chimeric virus reveals novel functions for HSV genes in capsid nuclear egress. J Virol 95:e0095721. 10.1128/JVI.00957-21. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 24.Cai W, Astor TL, Liptak LM, Cho C, Coen DM, Schaffer PA. 1993. The herpes simplex virus type 1 regulatory protein ICP0 enhances virus replication during acute infection and reactivation from latency. J Virol 67:7501–7512. 10.1128/JVI.67.12.7501-7512.1993. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 25.Mavromara-Nazos P, Roizman B. 1989. Delineation of regulatory domains of early (beta) and late (gamma 2) genes by construction of chimeric genes expressed in herpes simplex virus 1 genomes. Proc Natl Acad Sci USA 86:4071–4075. 10.1073/pnas.86.11.4071. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 26.Kim DB, Zabierowski S, DeLuca NA. 2002. The initiator element in a herpes simplex virus type 1 late-gene promoter enhances activation by ICP4, resulting in abundant late-gene expression. J Virol 76:1548–1558. 10.1128/jvi.76.4.1548-1558.2002. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 27.Jones KA, Tjian R. 1985. Sp1 binds to promoter sequences and activates herpes simplex virus ‘immediate-early’ gene transcription in vitro. Nature 317:179–182. 10.1038/317179a0. [DOI] [PubMed] [Google Scholar]
- 28.Thompson RL, Sawtell NM. 2019. Targeted promoter replacement reveals that herpes simplex virus type-1 and 2 specific VP16 promoters direct distinct rates of entry into the lytic program in sensory neurons in vivo. Front Microbiol 10:1624. 10.3389/fmicb.2019.01624. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 29.Hirai H, Tani T, Kikyo N. 2010. Structure and functions of powerful transactivators: VP16, MyoD and FoxA. Int J Dev Biol 54:1589–1596. 10.1387/ijdb.103194hh. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 30.Birkenheuer CH, Danko CG, Baines JD. 2018. Herpes simplex virus 1 dramatically alters loading and positioning of RNA polymerase II on host genes early in infection. J Virol 92:e02184-17. 10.1128/JVI.02184-17. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 31.Knipe DM, Cliffe A. 2008. Chromatin control of herpes simplex virus lytic and latent infection. Nat Rev Microbiol 6:211–221. 10.1038/nrmicro1794. [DOI] [PubMed] [Google Scholar]
- 32.Hu M, Depledge DP, Flores Cortes E, Breuer J, Schang LM. 2019. Chromatin dynamics and the transcriptional competence of HSV-1 genomes during lytic infections. PLoS Pathog 15:e1008076. 10.1371/journal.ppat.1008076. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 33.Dremel SE, DeLuca NA. 2019. Herpes simplex viral nucleoprotein creates a competitive transcriptional environment facilitating robust viral transcription and host shut off. Elife 8:e51109. 10.7554/eLife.51109. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 34.Michael N, Roizman B. 1993. Repression of the herpes simplex virus 1 alpha 4 gene by its gene product occurs within the context of the viral genome and is associated with all three identified cognate sites. Proc Natl Acad Sci USA 90:2286–2290. 10.1073/pnas.90.6.2286. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 35.Tunnicliffe RB, Lockhart-Cairns MP, Levy C, Mould AP, Jowitt TA, Sito H, Baldock C, Sandri-Goldin RM, Golovanov AP. 2017. The herpes viral transcription factor ICP4 forms a novel DNA recognition complex. Nucleic Acids Res 45:8064–8078. 10.1093/nar/gkx419. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 36.Wagner Lauren M, Bayer A, DeLuca Neal A. 2013. Requirement of the N-terminal activation domain of herpes simplex virus ICP4 for viral gene expression. J Virol 87:1010–1018. 10.1128/JVI.02844-12. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 37.Kuddus R, Gu B, DeLuca NA. 1995. Relationship between TATA-binding protein and herpes simplex virus type 1 ICP4 DNA-binding sites in complex formation and repression of transcription. J Virol 69:5568–5575. 10.1128/JVI.69.9.5568-5575.1995. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 38.Jonkers I, Lis JT. 2015. Getting up to speed with transcription elongation by RNA polymerase II. Nat Rev Mol Cell Biol 16:167–177. 10.1038/nrm3953. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 39.Orlando JS, Balliet JW, Kushnir AS, Astor TL, Kosz-Vnenchak M, Rice SA, Knipe DM, Schaffer PA. 2006. ICP22 is required for wild-type composition and infectivity of herpes simplex virus type 1 virions. J Virol 80:9381–9390. 10.1128/JVI.01061-06. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 40.Fox HL, Dembowski JA, DeLuca NA. 2017. A herpesviral immediate early protein promotes transcription elongation of viral transcripts. mBio 8:e00745-17. 10.1128/mBio.00745-17. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 41.Guo L, Wu WJ, Liu LD, Wang LC, Zhang Y, Wu LQ, Guan Y, Li QH. 2012. Herpes simplex virus 1 ICP22 inhibits the transcription of viral gene promoters by binding to and blocking the recruitment of P-TEFb. PLoS One 7:e45749. 10.1371/journal.pone.0045749. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 42.Zaborowska J, Baumli S, Laitem C, O'Reilly D, Thomas PH, O'Hare P, Murphy S. 2014. Herpes simplex virus 1 (HSV-1) ICP22 protein directly interacts with cyclin-dependent kinase (CDK)9 to inhibit RNA polymerase II transcription elongation. PLoS One 9:e107654. 10.1371/journal.pone.0107654. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 43.Isa NF, Bensaude O, Aziz NC, Murphy S. 2021. HSV-1 ICP22 is a selective viral repressor of cellular RNA polymerase II-mediated transcription elongation. Vaccines 9:1054. 10.3390/vaccines9101054. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 44.Hagglund R, Roizman B. 2004. Role of ICP0 in the strategy of conquest of the host cell by herpes simplex virus 1. J Virol 78:2169–2178. 10.1128/jvi.78.5.2169-2178.2004. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 45.McSwiggen DT, Hansen AS, Teves SS, Marie-Nelly H, Hao Y, Heckert AB, Umemoto KK, Dugast-Darzacq C, Tjian R, Darzacq X. 2019. Evidence for DNA-mediated nuclear compartmentalization distinct from phase separation. Elife 8:e47098. 10.7554/eLife.47098. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 46.Seyffert M, Georgi F, Tobler K, Bourqui L, Anfossi M, Michaelsen K. 2021. The HSV-1 transcription factor ICP4 confers liquid-like properties to viral replication compartments. Int J Mol Sci 22:4447. 10.3390/ijms22094447. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 47.Glass M, Everett RD. 2013. Components of promyelocytic leukemia nuclear bodies (ND10) act cooperatively to repress herpesvirus infection. J Virol 87:2174–2185. 10.1128/JVI.02950-12. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 48.Whisnant AW, Jürges CS, Hennig T, Wyler E, Prusty B, Rutkowski AJ, L'hernault A, Djakovic L, Göbel M, Döring K, Menegatti J, Antrobus R, Matheson NJ, Künzig FWH, Mastrobuoni G, Bielow C, Kempa S, Liang C, Dandekar T, Zimmer R, Landthaler M, Grässer F, Lehner PJ, Friedel CC, Erhard F, Dölken L. 2020. Integrative functional genomics decodes herpes simplex virus 1. Nat Commun 11:2038. 10.1038/s41467-020-15992-5. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 49.Sandri-Goldin RM. 2007. Initiation of transcription and RNA synthesis, processing and transport in HSV and VZV infected cells. In Arvin A, Campadelli-Fiume G, Mocarski E, Moore PS, Roizman B, Whitley R (ed), Human herpesviruses: biology, therapy, and immunoprophylaxis. Cambridge University Press, Cambridge, UK. [PubMed] [Google Scholar]
- 50.Mahat DB, Kwak H, Booth GT, Jonkers IH, Danko CG, Patel RK, Waters CT, Munson K, Core LJ, Lis JT. 2016. Base-pair-resolution genome-wide mapping of active RNA polymerases using precision nuclear run-on (PRO-seq). Nat Protoc 11:1455–1476. 10.1038/nprot.2016.086. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 51.Babraham Institute. 2020. Seqmonk (Version 1.48.0) [Computer Software]. https://www.bioinformatics.babraham.ac.uk/projects/seqmonk/.
- 52.Thorvaldsdóttir H, Robinson JT, Mesirov JP. 2013. Integrative Genomics Viewer (IGV): high-performance genomics data visualization and exploration. Brief Bioinform 14:178–192. 10.1093/bib/bbs017. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 53.Ramírez F, Ryan DP, Grüning B, Bhardwaj V, Kilpert F, Richter AS, Heyne S, Dündar F, Manke T. 2016. deepTools2: a next generation web server for deep-sequencing data analysis. Nucleic Acids Res 44:W160–W165. 10.1093/nar/gkw257. [DOI] [PMC free article] [PubMed] [Google Scholar]
Associated Data
This section collects any data citations, data availability statements, or supplementary materials included in this article.
Supplementary Materials
Fig. S1 and S5 and descriptions of appendices. Download jvi.01416-22-s0001.pdf, PDF file, 1.7 MB (1.8MB, pdf)
Appendix S1. Download jvi.01416-22-s0002.xlsx, XLSX file, 0.1 MB (149.6KB, xlsx)
Appendix S2. Download jvi.01416-22-s0003.xlsx, XLSX file, 0.1 MB (68.4KB, xlsx)
Data Availability Statement
The data is available on the GEO database under the accession numbers GSE202363 and GSE213098.






